Virtu Financial LLC Abb Vie Inc. Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $3.19 Million - $3.97 Million	24,099 New	24,099 $3.25 Million
Q4 2022 Feb 15, 2023	SELL	$138.31 - $165.87 $414,653 - $497,278	-2,998 Reduced 11.82%	22,369 $3.62 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $2.13 Million - $2.44 Million	15,853 Added 166.63%	25,367 $3.4 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $1.31 Million - $1.66 Million	9,514 New	9,514 $1.46 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $2.19 Million - $2.72 Million	-16,586 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$107.43 - $135.93 $598,170 - $756,858	5,568 Added 50.54%	16,586 $2.25 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $564,452 - $640,737	5,305 Added 92.86%	11,018 $1.19 Million
Q2 2021 Sep 17, 2021	BUY	$105.21 - $117.21 $601,064 - $669,620	5,713 New	5,713 $644,000
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $2.89 Million - $3.86 Million	-39,323 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $1.87 Million - $2.34 Million	25,942 Added 193.87%	39,323 $3.48 Million
Q3 2019 Nov 20, 2019	BUY	$62.98 - $75.72 $842,735 - $1.01 Million	13,381 New	13,381 $1.01 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $1.6 Million - $1.89 Million	-17,809 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$89.78 - $106.23 $1.01 Million - $1.2 Million	11,305 Added 173.82%	17,809 $1.65 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $976,502 - $1.31 Million	-10,613 Reduced 62.0%	6,504 $616,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $465,264 - $510,200	5,195 Added 43.57%	17,117 $1.66 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $832,751 - $1.06 Million	11,922	11,922 $1,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account